GleamWall
中文EN

PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Laboratory Analytical Instruments · Nasdaq · SEC CIK 1299130 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY2.0%
TTM net income YoY75.0%
TTM EPS YoY81.2%
Revenue 3-yr CAGR2.9%
Net income 3-yr CAGR—

Margins

Gross margin36.4%
Operating margin-83.5%
Net margin-82.5%
FCF margin-77.5%
EBITDA margin-77.4%

Returns

ROE-929.3%
ROA-16.7%
ROIC (approx.)—
Asset turnover0.20x

Leverage & solvency

Liabilities / assets104.4%
Debt / equity—
Current ratio4.92x
Interest coverage-18.15x

Cash quality & payout

Operating cash flow / net income0.90x
Accruals ratio-1.7%
Payout ratio—
Capex / revenue3.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$160.00M$154.01M
Cost of revenue$114.22M$116.73M
Gross profit$45.78M$37.28M
R&D expense$97.31M$134.92M
SG&A expense$141.49M$175.02M
Operating income-$553.86M-$474.31M
Interest expense$6.95M$13.41M
Pretax income-$546.06M-$309.54M
Income tax$318,000$316,000
Net income-$546.38M-$309.85M
EBITDA-$540.87M-$460.54M
EPS (basic)-1.82-1.13
EPS (diluted)-1.82-1.59
Dividends declared per share0.000.00
Weighted avg. shares (diluted)299.96M288.37M
Balance sheet
Cash & equivalents$63.71M$57.59M
Short-term investments$215.80M$334.56M
Receivables$35.45M$27.52M
Inventory$49.28M$58.76M
Current assets$375.05M$495.68M
PP&E, net$24.15M$30.50M
Goodwill$317.76M$317.76M
Intangibles$15.12M$389.57M
Total assets$784.08M$1.26B
Current liabilities$72.83M$66.30M
Short-term debt—$0
Total liabilities$778.73M$753.85M
Shareholders' equity$5.35M$506.59M
Shares outstanding301.96M294.42M
Cash flow statement
Operating cash flow-$111.21M-$206.06M
Capital expenditure$2.71M$6.19M
Free cash flow-$113.92M-$212.25M
Investing cash flow$115.45M$124.00M
Financing cash flow$3.43M-$42.99M
Depreciation & amortization$12.99M$13.77M
Stock-based compensation$41.67M$71.04M

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.